Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ACAD

Acadia Pharmaceuticals Inc

May 29 • 04:00PM ET

21.66

+0.03 0.14 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: AXSM XENE NBIX BMRN VKTX INCY MDGL ALKS KROS BIIB

| Held by: IJR VTI XBI VB IWM VBK VXF IBB SPSM IJT

Scroll to Statements

Index	RUT	P/E	9.86	EPS (ttm)	2.20	Insider Own	1.32%	Shs Outstand	171.09M	Perf Week	1.59%
Market Cap	3.71B	Forward P/E	28.18	EPS next Y	0.77	Insider Trans	-2.13%	Shs Float	168.98M	Perf Month	-2.43%
Enterprise Value	2.91B	PEG	-	EPS next Q	0.06	Inst Own	96.62%	Short Float	6.76%	Perf Quarter	-11.81%
Income	375.65M	P/S	3.39	EPS this Y	-83.08%	Inst Trans	0.01%	Short Ratio	6.28	Perf Half Y	-11.19%
Sales	1.10B	P/B	2.97	EPS next Y	97.54%	ROA	27.44%	Short Interest	11.42M	Perf YTD	-18.91%
Book/sh	7.29	P/C	4.36	EPS next 5Y	-14.50%	ROE	37.32%	52W High	28.35 -23.60%	Perf Year	-2.83%
Cash/sh	4.97	P/FCF	32.65	EPS past 3/5Y	- -	ROIC	29.19%	52W Low	19.69 10.01%	Perf 3Y	-12.59%
Dividend Est.	-	EV/EBITDA	31.37	Sales past 3/5Y	27.48% 19.39%	Gross Margin	91.47%	Volatility	2.53% 3.43%	Perf 5Y	-3.04%
Dividend TTM	-	EV/Sales	2.66	EPS Y/Y TTM	61.40%	Oper. Margin	7.39%	ATR (14)	0.70	Perf 10Y	-39.17%
Dividend Ex-Date	-	Quick Ratio	3.48	Sales Y/Y TTM	9.93%	Profit Margin	34.30%	RSI (14)	50.28	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	3.59	EPS Q/Q	-81.36%	SMA20	0.19%	Beta	0.84	Target Price	31.65
Payout	0.00%	Debt/Eq	0.04	Sales Q/Q	9.72%	SMA50	-0.43%	Rel Volume	0.96	Prev Close	21.63
Employees	798	LT Debt/Eq	0.03	Earnings	May 06 AMC	SMA200	-8.11%	Avg Volume	1.82M	Price	21.66
IPO	May 27, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	-60.40% -4.34%	Trades		Volume	1,744,274	Change	0.14%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)